XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Shirpoor M, Tofighi A, Shirpoor A, Chodari L, Pourjabali M. Investigating the effect of eight weeks of moderate-intensity aerobic exercise and taking curcumin supplement alone and in combination, on leptin levels and hepatic enzymes in older rats. Journal of Research in Applied and Basic Medical Sciences 2023; 9 (4) :263-271
URL: http://ijrabms.umsu.ac.ir/article-1-122-en.html
Department of Physiology, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran , a.tofighi@urmia.ac.ir
Abstract:   (189 Views)
Background & Aims: Non-alcoholic fatty liver disease is a common health problem in the world, and various studies have shown that the risk of developing the disease increases with age. In this study, we looked at the effects of 8 weeks of moderate-intensity aerobic exercise and curcumin use alone and in combination with each other on leptin and hepatic enzymes levels.
Materials & Methods: 32 male Wistar rats (24-month-old), and 8 male rats with the same breed (4-month-old) were examined in 5 groups (8 rats per group). Two groups were young and old control groups, and three groups included exercise group, curcumin group, and curcumin + exercise group. SPSS18 software and one-way ANOVA method and Tukey's post hoc test were utilized and 0.05> α was considered statistically significant.
Results: 8 weeks of aerobic exercise did not have a significant reduction in the level of leptin and hepatic enzymes, and 8 weeks of curcumin significantly reduced leptin levels and did not significantly reduce hepatic enzymes. Combined aerobic exercise and curcumin significantly reduced leptin and hepatic enzymes.
Conclusion: Concomitant use of curcumin with moderate-intensity aerobic exercise can have positive effects on reducing leptin levels and hepatic enzymes in patients with non-alcoholic fatty liver disease.
Full-Text [PDF 357 kb]   (92 Downloads) |   |   Full-Text (HTML)  (31 Views)  
Type of Study: orginal article | Subject: Special

1. Kim H, Kisseleva T, Brenner DA. Aging and liver disease. Curr Opin Gastroenterol 2015; 31(3): 184-91. [DOI:10.1097/MOG.0000000000000176] [PMID] []
2. Gong Z, Tas E, Yakar S, Muzumdar R. Hepatic lipid metabolism and non-alcoholic fatty liver disease in aging. Mol Cell Endocrinol 2017; 455: 115-30. [DOI:10.1016/j.mce.2016.12.022] [PMID]
3. Angrish MM, Kaiser JP, McQueen CA, Chorley BN. Tipping the Balance: Hepatotoxicity and the 4 Apical Key Events of Hepatic Steatosis. Toxicol Sci 2016; 150(2): 261-8. [DOI:10.1093/toxsci/kfw018] [PMID]
4. Orman ES, Odena G, Bataller R. Alcoholic liver disease: pathogenesis, management, and noveltargets for therapy. J Gastroenterol Hepatol 2013; 28 (Suppl 1): 77-84. [DOI:10.1111/jgh.12030] [PMID] []
5. Reddy JK, Sambasiva Rao M. Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am J Physiol Gastrointest Liver Physiol 2006; 290(5): G852-8. [DOI:10.1152/ajpgi.00521.2005] [PMID]
6. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346(16): 1221-31. [DOI:10.1056/NEJMra011775] [PMID]
7. Chang Y, Ryu S, Sung E, Jang Y. Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease. Clin Chem 2007 ;53(4):686-92. [DOI:10.1373/clinchem.2006.081257] [PMID]
8. Adolph TE, Grander C, Grabherr F, Tilg H. Adipokines and Non-Alcoholic Fatty Liver Disease: Multiple Interactions. Int J Mol Sci 2017; 18(8):1649. [DOI:10.3390/ijms18081649] [PMID] []
9. Polyzos SA, Kountouras J, Mantzoros CS. Leptin in nonalcoholic fatty liver disease: a narrative review. Metabolism 2015; 64(1): 60-78. [DOI:10.1016/j.metabol.2014.10.012] [PMID]
10. Wang Y, Zhou M, Lam KS, Xu A. Protective roles of adiponectin in obesity-related fatty liver diseases: mechanisms and therapeutic implications. Arq Bras Endocrinol Metabol 2009; 53(2): 201-12. [DOI:10.1590/S0004-27302009000200012] [PMID]
11. Lee Y, Wang MY, Kakuma T, Wang ZW, Babcock E, McCorkle K, Higa M, Zhou YT, et al, Liporegulation in diet-induced obesity. The antisteatotic role of hyperleptinemia. J Biol Chem 2001; 276(8): 5629-35. [DOI:10.1074/jbc.M008553200] [PMID]
12. Whitsett M, VanWagner LB. Physical activity as a treatment of non-alcoholic fatty liver disease: A systematic review. World J Hepatol 2015; 7(16): 2041-52. [DOI:10.4254/wjh.v7.i16.2041] [PMID] []
13. Shamsoddini A, Sobhani V, Chehreh ME, Alavian SM, Zaree A. Effect of Aerobic and Resistance Exercise Training on Liver Enzymes and Hepatic Fat in Iranian Men With Nonalcoholic Fatty Liver Disease. Hepat Mon 2015; 15(10): e31434. [DOI:10.5812/hepatmon.31434] [PMID] []
14. Kawanishi N, Yano H, Mizokami T, Takahashi M, Oyanagi E, Suzuki K. Exercise training attenuates hepatic inflammation, fibrosis and macrophage infiltration during diet induced-obesity in mice. Brain Behav Immun 2012; 26(6): 931-41. [DOI:10.1016/j.bbi.2012.04.006] [PMID]
15. Barzegarzadeh-Zarandi H, Dabidy-Roshan V. Changes in some liver enzymes and blood lipid level following interval and continuous regular aerobic training in old rats. J Shahrekord Univ Med Sci 2012; 14(5): 13-23. [Google Scholar]
17. Stickel F, Schuppan D. Herbal medicine in the treatment of liver diseases. Dig Liver Dis 2007; 39(4): 293-304. [DOI:10.1016/j.dld.2006.11.004] [PMID]
18. Schuppan D, Jia JD, Brinkhaus B, Hahn EG. Herbal products for liver diseases: a therapeutic challenge for the new millennium. Hepatology 1999; 30(4): 1099-104. [DOI:10.1002/hep.510300437] [PMID]
19. Kunchandy E, Rao MN. Oxygen radical scavenging activity of curcumin. Int J Pharm1990; 58(3): 237-40. [DOI:10.1016/0378-5173(90)90201-E]
20. Zhou H, S Beevers C, Huang S. The targets of curcumin. Curr Drug Targets 2011; 12(3): 332-47. [DOI:10.2174/138945011794815356] [PMID] []
21. Ahren BO, Mansson S, Gingerich RL, Havel PJ. Regulation of plasma leptin in mice: influence of age, high-fat diet, and fasting. Am J Physiol 1997; 273 (1):R113-20. [DOI:10.1152/ajpregu.1997.273.1.R113] [PMID]
22. WANG ZW, PAN WT, Lee Y, Kakuma T, ZHOU YT, Unger RH. The role of leptin resistance in the lipid abnormalities of aging. FASEB J 2001; 15(1): 108-14. [DOI:10.1096/fj.00-0310com] [PMID]
23. Kraemer RR, Kraemer GR, Acevedo EO, Hebert EP, Temple E, Bates M, et al. Effects of aerobic exercise on serum leptin levels in obese women. Eur J Appl Physiol 1999; 80: 154-8. [DOI:10.1007/s004210050572] [PMID]
24. Houmard JA, Cox JH, MacLean PS, Barakat HA. Effect of short-term exercise training on leptin and insulin action. Metabolism 2000; 49(7): 858-61. [DOI:10.1053/meta.2000.6751] [PMID]
25. Hayase H, Nomura S, Abe T, Izawa T. Relation between fat distributions and several plasma adipocytokines alter exercise trainingin premenopausal and postmenopausal women. J Physiol Anthropol 2002; 21(2): 105-13. [DOI:10.2114/jpa.21.105] [PMID]
26. Miyatake N, Takahashi K, Wada J, Nishikawa H, Morishita A, Suzuki H, et al, Changes in serum leptin concentrations in overweight Japanese men after exercise. Diabetes Obes Metab 2004; 6(5): 332-7. [DOI:10.1111/j.1462-8902.2004.00351.x] [PMID]
27. Song WY, Choi JH. Korean Curcuma longa L. induces lipolysis and regulates leptin in adipocyte cells and rats. Nutr Res Pract 2016; 10(5): 487-93. [DOI:10.4162/nrp.2016.10.5.487] [PMID] []
28. Navekar R, Rafraf M, Ghaffari A, Asghari-Jafarabadi M, Khoshbaten M. Turmeric Supplementation Improves Serum Glucose Indices and Leptin Levels in Patients with Nonalcoholic Fatty Liver Diseases. J Am Coll Nutr 2017; 36(4): 261-7. [DOI:10.1080/07315724.2016.1267597] [PMID]
29. Moradi, K, et al, Effect of curcumin supplementation and resistance training in patients with nonalcoholic fatty liver disease. J Med Plants 2016; 15 (60):161-172. [Google Scholar]
30. Panahi Y, Kianpour P, Mohtashami R, Jafari R, Simental-Mendía LE, Sahebkar A. Efficacy and safety of phytosomal curcumin in non-alcoholic fatty liver disease: a randomized controlled trial. Drug Res 2017; 67: 244-51. [DOI:10.1055/s-0043-100019] [PMID]
31. Kim HY, Park EJ, Joe EH, Jou I. Curcumin suppresses Janus kinase-STAT inflammatory signaling through activation of Src homology 2 domain-containing tyrosine phosphatase 2 in brain microglia. J Immunol 2003; 171(11): 6072-9. [DOI:10.4049/jimmunol.171.11.6072] [PMID]
32. Kumar A, Dhawan S, Hardegen NJ, Aggarwal BB. Curcumin (Diferuloylmethane) inhibition of tumor necrosis factor (TNF)-mediated adhesion of monocytes to endothelial cells by suppression of cell surface expression of adhesion molecules and of nuclear factor-kappaB activation. Biochem Pharmacol 1998; 55(6): 775-83. [DOI:10.1016/S0006-2952(97)00557-1] [PMID]
33. ABE Y, Hashimoto SH, HORIE T. Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol Res 1999; 39(1): 41-7. [DOI:10.1006/phrs.1998.0404] [PMID]
34. Suzuki A, Abdelmalek MF. Nonalcoholic fattyliver disease in women. Res. J. Womens Health (Lond) 2009; 5(2): 191 - 203. [DOI:10.2217/17455057.5.2.191] [PMID]
35. Frith J, Jones D, Newton JL. Chronic liver disease in an ageing population. Age Ageing 2009; 38(1): 11-8. [DOI:10.1093/ageing/afn242] [PMID]
36. Mikami T, Sumida S, Ishibashi Y, Ohta S. Endurance exercise training inhibits activity of plasma GOT and liver caspase-3 of mice [correction of rats] exposed to stress by induction of heat shock protein 70. J Appl Physiol 2004; 96(5): 1776-81. [DOI:10.1152/japplphysiol.00795.2002] [PMID]
37. Haus JM, Solomon TP, Kelly KR, Fealy CE, Kullman EL, Scelsi AR, et al. Improved hepatic lipid composition following short-term exercise in nonalcoholic Fatty liver disease. J Clin Endocrinol Metab 2013. 98(7): 1181-8. [DOI:10.1210/jc.2013-1229] [PMID] []
38. Hallsworth K, Avery L, Trenell MI. Targeting lifestyle behavior change in adults with NAFLD during a 20-min consultation: summary of the dietary and exercise literature. Curr Gastroenterol Rep 2016; 18(3): 11. [DOI:10.1007/s11894-016-0485-1] [PMID] []

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2023 CC BY-NC 4.0 | Journal of Research in Applied and Basic Medical Sciences

Designed & Developed by : Yektaweb